chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since receiving the second dose of Pfizer/BioNtech Covid-19 vaccine my resting HR has elevated from a baseline of 60-70 to 110-120 at almost all times, making it very difficult to exercise or exert myself physically at all. I have upwards of 60 palpitations a day, compared to a baseline of 0 or 1 a day, which are extremely troubling. I've had an EKG, Cardiac Echo and Halter Monitor all of which were inconclusive. I am consistently now out of breath and often get faint when standing / have a great deal of fatigue preventing me from normal activities. It looks likely that the vaccine triggered a reactivation of latent Ebsteinn-Barr Virus. Lastly, I have had peripheral neuropathy in my left arm and feet on a weekly basis (something I have never experienced before) and more chronic pain.
Hot red rash surrounding injection site lasting about 1 week and now with an area of hyperpigmentation extending from the site distally down the back of the arm.
Staff was administered expired vaccine which was mislabeled with a frozen expiration date rather than a refrigerated expiration date
1 day after: Painful joints, extreme fatigue. Headaches throughout the day.  2 days after: Painful lymph nodes in neck (associated painful swallowing). Joint pain has reached max level. Nighttime fever. Fatigue also still present. Headaches throughout the day. 3 days after: Lymph nodes in neck have reached maximum pain level. Joint pain subsiding but still present. Fatigue subsiding but still present. Headaches have subsided.
She did not get her 2nd shot 20APR2021 as a nurse advised against it.; Worsening severe tachycardia 24/7,heart rate got up to 112 BPM; couldn't breathe; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (couldn't breathe), PRODUCT DOSE OMISSION ISSUE (She did not get her 2nd shot 20APR2021 as a nurse advised against it.) and TACHYCARDIA (Worsening severe tachycardia 24/7,heart rate got up to 112 BPM) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DYSPNOEA (couldn't breathe) and TACHYCARDIA (Worsening severe tachycardia 24/7,heart rate got up to 112 BPM). On 11-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (She did not get her 2nd shot 20APR2021 as a nurse advised against it.). At the time of the report, DYSPNOEA (couldn't breathe), PRODUCT DOSE OMISSION ISSUE (She did not get her 2nd shot 20APR2021 as a nurse advised against it.) and TACHYCARDIA (Worsening severe tachycardia 24/7,heart rate got up to 112 BPM) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Heart rate: 112 (High) 112 BPM.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Death Anasarca Hyperammonemia Altered mental status Pulmonary edema Hypermagnesemia ARF (acute renal failure) Anemia
101 fever, chills, weakness,  dizziness,  nausea,  heart palpitations.
Migraine from first shot to 2/3 days after 2nd shot. Passing out since 2nd shot. First time was about two weeks after 2nd shot. Passed out four times after second shot. Never passed out before. Fatigue, headaches (that were controlled). Light headed, dizzy, lose focus sweats and concentration. Ringing on ears, foggy feeling and left eye almost gets cloudy like I can?t see out of it every once and a while.
sick; more than 35 days passed since the first dose and she has not received the second dose; vaccination went horribly; couldn't wake up,forced herself to wake up, was in and out; blacked out, was out for 38hs,opened her eyes and everything was dark although all the lights in her bedroom were on, couldn't see, everything was dark, it was shadowed; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (blacked out, was out for 38hs,opened her eyes and everything was dark although all the lights in her bedroom were on, couldn't see, everything was dark, it was shadowed) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced LOSS OF CONSCIOUSNESS (blacked out, was out for 38hs,opened her eyes and everything was dark although all the lights in her bedroom were on, couldn't see, everything was dark, it was shadowed) (seriousness criterion medically significant) and SOMNOLENCE (couldn't wake up,forced herself to wake up, was in and out). On an unknown date, the patient experienced ILLNESS (sick), PRODUCT DOSE OMISSION ISSUE (more than 35 days passed since the first dose and she has not received the second dose) and VACCINATION COMPLICATION (vaccination went horribly). In July 2021, LOSS OF CONSCIOUSNESS (blacked out, was out for 38hs,opened her eyes and everything was dark although all the lights in her bedroom were on, couldn't see, everything was dark, it was shadowed) and SOMNOLENCE (couldn't wake up,forced herself to wake up, was in and out) had resolved. At the time of the report, ILLNESS (sick) and VACCINATION COMPLICATION (vaccination went horribly) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (more than 35 days passed since the first dose and she has not received the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication was not provided by the reporter.  She was sick on the day that she was supposed to get her second dose and she missed it. She talked to her doctor and she said if she could not get it by last Friday (27Aug2021), then she had to start all over again. She was in her doctor's office this week again and she said "go ahead and get the second shot, she would be fine". So she was not sure what to do. After hearing the information, she said she went to get it done this week.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage, and route of administration not provided), administered by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2016, the patient was treated at a hospital for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
I went in for my Yearly. while I was there, I got my frist EVER flu shot.  I was fine when I went in. About 2 hours after getting it, i felt misserable!  I was achey, which I knew would happen.  So I gave it a few days.  I felt some what better, but when I was rubbing my head, Imoved my hand to me ear, and felt a bump behind it.  When I pushed on it, my entire ear started hurting.  The next day, I was really bad.  I was runnng a low fever, and was sneezing.  I took some meds, and laid down.  The next day, it was still bothering me. i went to my PCP on that monday. I found out i had a nasty inner ear infection, which i had only had one in about 3 years.  So he gave me some antis, and i went home.  I took them and the bump went away.  I felt ok till about a week ago.  this was a week after I finished my antis.  I felt around again and the bump was back!  It did go away, but last nite, i felt around becasue it was hurting, and found it yet again.  this time it was in front of my ear.  i have told my PCP i think its related to my shot but he turned his head away and ignored it.  ive been laughed at, and noone belives me!  I am healthy and have only had 1 infection in 3 years. this isnt me!!!
Shingles involving left upper extremity. Started with generalized body aches, fatigue and pruritus then developed rash that started on her left palm and spread to her axilla and then her elbow. Rash is painful and pruritic and vesicular in appearance. She was started on valtrex on 5/21/19
Slight numbness in left cheek. Sensation can be described as like one had a novocain injection 3 hours earlier. It has persisted for 2 days. All functions (speech, eating, drinking, etc) are normal. No treatment.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 01-JUN-2013, the patient was vaccinated with a dose of VAQTA, (lot # H019104, expiry date 19-JUL-2015), which was exposed to 31 degree Fahrenheit. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
May or may not have received a second dose of Gardasil or Gardasil 9; May or may not have received a second dose of Gardasil or Gardasil 9; No adverse effect reported; This spontaneous report was received from a physician and refers to currently 22 year old patient of unknown gender.  On an unknown date, the patient was vaccinated with the first dose of either quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine(GARDASIL) or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (strength, frequency, route of administration, lot# and expiration date were not reported).    It was reported that the patient was 18 years old when the first dose of the vaccine was received, and a second dose may or may not have been administered in an unknown date. No adverse effects were reported.
Pfizer-Biontech Covid-19 Bivalent vaccine was administered for first primary dose instead of the Pfizer-Biontech Covid-19 Monovalent vaccine
Pt received shot at 1145. At 1220, pt reported sx fo puffy eye lids (no puffiness visible outwardly), ears ringing, blurry vision, feeling hot, weakness in muscles. VS: BP 126/68, P85, RR18, O2 99% RA, T98.6F. Pt takes benadryl 25mg po bid. Last dose 0400 today. Pt reports multiple previous hospitalizations for congestive heart failure, tachycardia, and bradycardia.  She takes ?1500 of Levothyronine? and ?Mididrine four times a day to raise my blood pressure.? She does not want more benadryl at this time. She is calm outwardly. No signs of distress noted outwardly. Diminished lung sounds in bilat lower lobes. Pt smokes cigarettes. Dr consulted. Pt advised to wait in high risk obs for another 30 min to see if symptoms resolve. After about 5 minutes, pt requested EMS. No worsening conditions noted or reported. EMS called and came to assess pt. Pt left via EMS to go to hospital at approximately 12:15pm. Pt notified to follow up with her PCP prior to second dose of vaccine.
itchy rash at the injection site 3 inches in diameter; itchy rash at the injection site 3 inches in diameter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (itchy rash at the injection site 3 inches in diameter) and VACCINATION SITE PRURITUS (itchy rash at the injection site 3 inches in diameter) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE RASH (itchy rash at the injection site 3 inches in diameter) and VACCINATION SITE PRURITUS (itchy rash at the injection site 3 inches in diameter). At the time of the report, VACCINATION SITE RASH (itchy rash at the injection site 3 inches in diameter) and VACCINATION SITE PRURITUS (itchy rash at the injection site 3 inches in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jan-2021 and was forwarded to Moderna on 24-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (itchy rash at the injection site 3 inches in diameter) and VACCINATION SITE PRURITUS (itchy rash at the injection site 3 inches in diameter) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE RASH (itchy rash at the injection site 3 inches in diameter) and VACCINATION SITE PRURITUS (itchy rash at the injection site 3 inches in diameter). At the time of the report, VACCINATION SITE RASH (itchy rash at the injection site 3 inches in diameter) and VACCINATION SITE PRURITUS (itchy rash at the injection site 3 inches in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  No treatment details were reported.
Red; Swelling arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red) and PERIPHERAL SWELLING (Swelling arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red) and PERIPHERAL SWELLING (Swelling arm). At the time of the report, ERYTHEMA (Red) and PERIPHERAL SWELLING (Swelling arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications use were not reported No treatment information were reported.  .
Approximately 1 1/2 hours after injection, ears began ringing very loudly. It is now 72 hours after injection and ears are still ringing. Does not come and go, but is constant.
About 8 weeks after the second Covid-19 vaccine a routine blood test for an unrelated condition indicated a severe drop in platelets to 17,000. The patient exhibited and noticed no symptoms. Follow up bloodwork over the next three days showed a further drop to 12,000. Patient was referred to Dr., a Hematology and Medical Oncology specialist. She immediately had the patient go to the Emergency Room and then had her admitted to Hospital. The patient was diagnosed with Immune thrombocytopenia (ITP). At the time, specialist noted that she had a second patient with the identical symptoms who received their second Pfizer shot a month or so earlier. During the hospital stay and for a few weeks after, the patient received infusions of Rituximab and was placed on the oral medication Promacta. At the end of the 14-day stay, the patient's platelet count increased to 17,000. Over the next three weeks as an outpatient, while on Promacta, the platelet count rose to over 500,00 and the patient was told to discontinue all use of Promacta. The patient is receiving weekly blood tests and her status is being monitored.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On 30-MAR02916, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 (which had a lot # of K009874 and expiration date of 19-MAR-2016; however, dose, dosage number and route of administration were not reported). Nonetheless, no adverse effects were reported and no product quality complaint was involved. Additional information has been requested.
LIGHT SENSITIVITY; HAVENT FELT GOOD; STOMACH PAINS AND CRAMPS; VOMITING; SEVERE HEADACHE; NAUSEA; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. Batch number was not reported. As Per procedure no follow up will be required for this case. No concomitant medications were reported.  On APR-2021, the subject experienced light sensitivity. On APR-2021, the subject experienced havent felt good. On APR-2021, the subject experienced stomach pains and cramps. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced severe headache. On APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe headache, stomach pains and cramps, nausea, vomiting, light sensitivity and havent felt good was not reported. This report was non-serious.
Normal pain turning to nausea. After 12 hours patient's temperature dropped to 74.3 resulting in shaking and muscle spasms. I did not go to the hospital because we live in a remote area. I used hot tea warm clothes and blankets until my temperature started to come back up. It rose to 100.5 and I took one 500mg aspirin and it gradually dropped back to normal. This was over a period of 8 hours. I was no longer nauseated and was able to eat and drink but was very weak for the rest of the day.
started crying hard @ 7PM uncontrollable 2-3 hr;left leg swelled-extremely red & sore;pt given Motrin;t103-104 used Comfrey alcohol on legs & this worked better than anything;slept on couch w/leg elevated & restless thru noc; red localized
8 days following vax, awoke in the morning with shortness of breath and a feeling of being punched in chest. Am now at 5 months post event with little to no improvement. Have had pulmonary. cardiology and neurology testing. No medical data thus fas has been found to explain ongoing debilitating symptoms. Have never tested posted for Covid.
Vaccine 12-18-12. On 12-21-12 from upper mid shoulder to elbow swollen and red,. On 12-24-12, black and brown coloring near elbow.
This spontaneous report was received from a Nurse professional via a company representative regarding her mother (age unknown). Pertinent medical history and concurrent conditions were unspecified. On an unknown date the patient was vaccinated with PNEUMOVAX 23, injection due to a chronic respiratory issue (dose and route not reported). No other concomitant therapies reported. On an unknown date, the patient developed pneumococcal disease, a strain which PNEUMOVAX 23, was supposed to cover. On an unknown date in March 2014 (about 6 months ago) the patient died from an aneurysm which was after she developed the pneumococcal disease. The lab diagnostic tests were unspecified. It was unknown whether patient sought medical attention. The outcome of the event aneurysm was reported as fatal. The outcome of the event pneumococcal disease was unknown. The causality of the events was unspecified. No PQC involved. Additional information is not expected.
Patient started having dizziness at 1459. Took her back to an exam room and did vitals. Patient was hypertensive and admits to taking her BP meds this morning. She denies any shortness of breath, hives, chest pain, or chest tightness. Monitored patient for x2 rounds of vitals and patient remains hypertensive. Nurse STAT called at 1518. She is evaluated by RN and she is transferred to the urgent care for further evaluation. No medications administered. Patient took benadryl 20 min prior to her vaccine.
Began experiencing a sick stomach and then a runny nose.  Took an At-Home Test and tested positive for Covid 19
Reaction to immunization received 3/3/08 and redness and swollen (L) thigh Temp. 101 deg reaction 7cm x 6cm
PT WAS GIVEN MODERNA FOR THE FIRST DOSE AND 28 DAYS LATER WAS GIVEN PFIZER FOR THE SECOND DOSE
Pt devel a raised, red rash & edema @ inject site, which spread to a large portion of arm, 1 wk p/receiving Td; Rash & edema subsequently dissipated w/o treatment;
Pt reported a headache and chills (unsure if she was febrile) the same night as receiving the vaccine earlier that day. Pt reported it last a few hours until she went to bed. She called this morning and stated that she is feeling back to normal.
My son woke up with one side of his face swollen, and his face and parts of his body (arm, back, groin area, legs) in hives. We administered Benadryl (as per the pediatrician's order) and also put calamine lotion on the rash. During the remainder of the day and onto yesterday morning the hives would sporadically appear and disappear.
Immediate tingling = arm and numbness in fingers, resolved after 24h. Residual discomfort. Transient weakness 10 days later.